1
|
Wirth A, Duda J, Distl O. Impact of Inbreeding and Ancestral Inbreeding on Longevity Traits in German Brown Cows. Animals (Basel) 2023; 13:2765. [PMID: 37685029 PMCID: PMC10486702 DOI: 10.3390/ani13172765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/26/2023] [Accepted: 08/28/2023] [Indexed: 09/10/2023] Open
Abstract
A recent study on the population structure of the German Brown population found increasing levels of classical and ancestral inbreeding coefficients. Thus, the aim of this study was to determine the effects of inbreeding depression and purging on longevity traits using classical and ancestral inbreeding coefficients according to Kalinowski (2002) (Fa_Kal, FNew), Ballou (1997) (Fa_Bal), and Baumung (2015) (Ahc). For this purpose, uncensored data of 480,440 cows born between 1990 and 2001 were available. We analyzed 17 longevity traits, including herd life, length of productive life, number of calvings, lifetime and effective lifetime production for milk, fat, and protein yield, the survival to the 2nd, 4th, 6th, 8th, and 10th lactation number, and the culling frequencies due to infertility, or udder and foot and leg problems. Inbreeding depression was significant and negative for all traits but for culling due to udder and to foot and leg problems. When expressed in percentages of genetic standard deviations, inbreeding depression per 1% increase in inbreeding was -3.61 to -10.98%, -2.42 to -2.99%, -2.21 to -4.58%, and 5.13% for lifetime production traits, lifetime traits, survival rates, and culling due to infertility, respectively. Heterosis and recombination effects due to US Brown Swiss genes were positive and counteracted inbreeding depression. The effects of FNew were not significantly different from zero, while Fa_Kal had negative effects on lifetime and lifetime production traits. Similarly, the interaction of F with Fa_Bal was significantly negative. Thus, purging effects could not be shown for longevity traits in German Brown. A possible explanation may be seen in the breed history of the German Brown, that through the introgression of US Brown Swiss bulls ancestral inbreeding increased and longevity decreased. Our results show, that reducing a further increase in inbreeding in mating plans is advisable to prevent a further decline in longevity due to inbreeding depression, as purging effects were very unlikely in this population.
Collapse
Affiliation(s)
- Anna Wirth
- Institute of Animal Breeding and Genetics, University of Veterinary Medicine Hannover (Foundation), 30559 Hannover, Germany;
| | - Jürgen Duda
- Landeskuratorium der Erzeugerringe für Tierische Veredelung in Bayern e.V. (LKV), 80687 München, Germany;
| | - Ottmar Distl
- Institute of Animal Breeding and Genetics, University of Veterinary Medicine Hannover (Foundation), 30559 Hannover, Germany;
| |
Collapse
|
2
|
Gaul S, Shahzad K, Medert R, Gadi I, Maeder C, Schumacher D, Wirth A, Fatima S, Boeckel JN, Khawaja H, Brune M, Nawroth PP, Isermann B, Laufs U, Freichel M. A novel direct inducible nongenetic murine model of diabetes-aggravated atherosclerosis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.3078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and aims
Atherosclerosis, the main pathology underlying cardiovascular diseases is accelerated in diabetic patients (1,2). Genetic mouse models require breeding efforts which are time-consuming and costly. Our aim was to establish a new nongenetic model of inducible metabolic risk factors that mimics hyperlipidemia, hyperglycemia, or both and allows the detection of phenotypic differences dependent on the metabolic stressor(s) on any genetic background.
Methods and results
Wild type mice were injected with gain-of-function PCSK9D377Y (proprotein convertase subtilisin/kexin type 9) mutant adeno-associated viral particles (AAV) and streptozotocin (STZ) and fed either a high-fat diet (HFD) or high-cholesterol/high fat-diet (Paigen diet, PD) for 12 and 20 weeks. LDLR KO mice were used as reference control. Combined hyperlipidemic and hyperglycemic mice (HGHCi), but not hyperlipidemia (HCi) alone, displayed characteristic features of aggravated atherosclerosis characterized by larger and less stable plaques (necrotic core area in HGHCi HFD: 24% vs HCi HFD: 13% vs LDLR KO HFD: 18% area, at 20 weeks p<0.05; fibrous cap thickness in HGHCi: 13 μm vs HCi HFD: 23 μm vs LDLR KO HFD: 17 μm, at 20 weeks, p<0.05) which contained more macrophages (MOMA-2 in HGHCi HFD: 27% vs HCi HFD: 19% vs LDLR KO HFD: 46% area/plaque, at 20 weeks, p<0.05) and less smooth muscle cells (α-SMA in HGHCi HFD: 12% vs HCi HFD: 25% vs LDLR KO HFD: 18% area/plaque, at 20 weeks, p<0.05), on both HFD or PD diet. Diabetic atherosclerotic mice (HGHCi) fed a HFD showed 37% plaque area (of total lumen) compared to 16% plaque area in non-diabetic mice (HCi HFD) and 17% in LDLR KO HFD after 12 weeks; and 43% (HGHCi HFD) vs. 29% (HCi HFD) vs 39% plaque area (LDLR KO HFD) after 20 weeks (Figure 1A, B). Differences between the diabetic HGHCi and non-diabetic HCi HFD mice were confirmed using RNA-seq analysis of aortic tissue, revealing that significantly more genes were dysregulated in mice with combined hyperlipidemia and hyperglycemia than in the hyperlipidemia-only group. The HGHCi-associated genes were related to pathways regulating inflammation (increased Cd68, iNos, and Tnfa expression) and extracellular matrix degradation (Adamts4 and Mmp14) (Figure 1C). When comparing HFD with PD, the PD aggravated atherosclerosis to a greater extent in mice and showed plaque formation after 8 weeks (HGHCi PD: 48% plaque area vs. HCi PD: 30% plaque area), therefore, representing a direct inducible hyperglycemic atherosclerosis model compared with HFD-fed mice, in which atherosclerosis is severe by 8 weeks.
Conclusion
We established a nongenetic direct inducible mouse model of diabetes-aggravated atherosclerosis allowing comparative analyses of atherosclerosis in diabetic and non-diabetic conditions and its modification by diet, allowing analyses of multiple metabolic hits in mice.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Deutsche Forschungsgemeinschaft (DFG)
Collapse
Affiliation(s)
- S Gaul
- University Hospital Leipzig, Klinik und Poliklinik für Kardiologie , Leipzig , Germany
| | - K Shahzad
- University Hospital Leipzig, Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostic , Leipzig , Germany
| | - R Medert
- University of Heidelberg, Institute of Pharmacology , Heidelberg , Germany
| | - I Gadi
- University Hospital Leipzig, Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostic , Leipzig , Germany
| | - C Maeder
- University Hospital Leipzig, Klinik und Poliklinik für Kardiologie , Leipzig , Germany
| | - D Schumacher
- University of Heidelberg, Institute of Pharmacology , Heidelberg , Germany
| | - A Wirth
- University of Heidelberg, Institute of Pharmacology , Heidelberg , Germany
| | - S Fatima
- University Hospital Leipzig, Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostic , Leipzig , Germany
| | - J N Boeckel
- University Hospital Leipzig, Klinik und Poliklinik für Kardiologie , Leipzig , Germany
| | - H Khawaja
- University Hospital Leipzig, Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostic , Leipzig , Germany
| | - M Brune
- University of Heidelberg, Internal Medicine I and Clinical Chemistry , Heidelberg , Germany
| | - P P Nawroth
- University of Heidelberg, Internal Medicine I and Clinical Chemistry , Heidelberg , Germany
| | - B Isermann
- University Hospital Leipzig, Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostic , Leipzig , Germany
| | - U Laufs
- University Hospital Leipzig, Klinik und Poliklinik für Kardiologie , Leipzig , Germany
| | - M Freichel
- University of Heidelberg, Institute of Pharmacology , Heidelberg , Germany
| |
Collapse
|
3
|
Tran K, Tsang R, Suh C, Yoon H, Taguchi S, Oguchi M, Gunther J, Dabaja B, Wright C, Plastaras J, Elsayad K, Ng A, Binkley M, Brady J, Wang X, Levis M, Harris M, Bressel M, MacManus M, Wirth A. An International, Multi-Centre Study of Radiotherapy for Bilateral Indolent Orbital Adnexal Lymphomas (IOAL). Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
4
|
Miller JH, Gilbertson M, MacManus MP, Wirth A, Opat SS, Gregory GP. SALVAGE RADIOTHERAPY ASSOCIATES WITH DURABLE RESPONSE FOR A SUBSET OF PATIENTS WITH LIMITED STAGE REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.39_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- J. H Miller
- Monash Health, Monash Haematology Melbourne Australia
| | - M Gilbertson
- Monash Health, Monash Haematology Melbourne Australia
| | - M. P MacManus
- Peter MacCallum Cancer Centre, Radiation Oncology Melbourne Australia
| | - A Wirth
- Peter MacCallum Cancer Centre, Radiation Oncology Melbourne Australia
| | - S. S Opat
- Monash Health, Monash Haematology Melbourne Australia
| | - G. P Gregory
- Monash Health, Monash Haematology Melbourne Australia
| |
Collapse
|
5
|
Newman S, Bucknell N, Bressel M, Tran P, Campbell BA, David S, Haghighi N, Hanna GG, Kok D, MacManus M, Phillips C, Plumridge N, Shaw M, Wirth A, Wheeler G, Ball D, Siva S. Long-term Survival with 18-Fluorodeoxyglucose Positron Emission Tomography-directed Therapy in Non-small Cell Lung Cancer with Synchronous Solitary Brain Metastasis. Clin Oncol (R Coll Radiol) 2020; 33:163-171. [PMID: 33129655 DOI: 10.1016/j.clon.2020.10.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Revised: 07/28/2020] [Accepted: 10/13/2020] [Indexed: 11/27/2022]
Abstract
AIMS At diagnosis, <1% of patients with non-small cell lung cancer (NSCLC) have synchronous solitary brain metastasis (SSBM). In prior cohorts without 18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) staging, definitive treatment to intracranial and intrathoracic disease showed a 5-year overall survival (OS) of 11-21%. We investigated the long-term survival outcomes for patients with SSBM NSCLC, diagnosed in the FDG-PET/CT era and treated definitively with local therapies to both intracranial and intrathoracic sites of disease. MATERIALS AND METHODS This retrospective study assessed patients staged with FDG-PET/CT who received definitive lung and SSBM treatment from February 1999 to December 2017. A lung-molecular graded prognostic assessment (lung-molGPA) score was assigned for each patient using age, performance status score, and, where carried out, molecular status. Overall survival and progression-free survival (PFS) were calculated using Kaplan-Meier methods. Cox proportional hazard models determined OS and PFS prognostic factors. RESULTS Forty-nine patients newly diagnosed with NSCLC and SSBM had a median age of 63 years (range 34-76). The median follow-up of all patients was 3.9 years. Thirty-three patients (67%) had ≥T2 disease, 23 (47%) had ≥N2. At 2 years, 45% of first failures were intracranial only (95% confidence interval 30-59). At 3 and 5 years, OS was 45% (95% confidence interval 32-63) and 30% (95% confidence interval 18-51), respectively. In ≥N1 disease, 5-year OS was 34% (95% confidence interval 18-63). The 3- and 5-year PFS was 8% (95% confidence interval 3-22) and 0%, respectively. Higher lung-molGPA was associated with longer OS (hazard ratio 0.26, 95% confidence interval 0.11-0.61, P = 0.002). Higher lung-molGPA (hazard ratio 0.33, 95% confidence interval 0.15-0.71, P = 0.005) and lower N-stage (hazard ratio 1.56, 95% confidence interval 1.13-2.15, P = 0.007) were associated with longer PFS. CONCLUSIONS Definitive treatment of patients with NSCLC and SSBM staged with FDG-PET/CT can result in 5-year survivors, including those with ≥N1 disease.
Collapse
Affiliation(s)
- S Newman
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - N Bucknell
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia
| | - M Bressel
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - P Tran
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - B A Campbell
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia
| | - S David
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - N Haghighi
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - G G Hanna
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia
| | - D Kok
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - M MacManus
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia
| | - C Phillips
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - N Plumridge
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - M Shaw
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - A Wirth
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - G Wheeler
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia
| | - D Ball
- Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia
| | - S Siva
- Peter MacCallum Cancer Centre, Radiation Oncology, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Victoria, Australia.
| |
Collapse
|
6
|
Fog L, Wirth A, MacManus M, Downes S, Grace M, Moggre A, Mugabe K, Neveri G, Nourbehesht L, Panetieri V, Pope D, Sim L, Stanton C, Steer B, Stewart A, Ungureanu E, Kron T. PO-1464: Total body irradiation practice in Australia and New Zealand: Results of a Survey. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01482-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Plotkin-Swing B, Wirth A, Gochnauer D, Rahman T, McAlpine KE, Gupta S. Crossed-beam slowing to enhance narrow-line ytterbium magneto-optic traps. Rev Sci Instrum 2020; 91:093201. [PMID: 33003806 DOI: 10.1063/5.0011361] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Accepted: 08/15/2020] [Indexed: 06/11/2023]
Abstract
We demonstrate a method to enhance the atom loading rate of a ytterbium (Yb) magneto-optic trap (MOT) operating on the 556 nm 1S0 → 3P1 intercombination transition (narrow linewidth Γg = 2π × 182 kHz). Following traditional Zeeman slowing of an atomic beam near the 399 nm 1S0 → 1P1 transition (broad linewidth Γp = 2π × 29 MHz), two laser beams in a crossed-beam geometry, frequency tuned near the same transition, provide additional slowing immediately prior to the MOT. Using this technique, we observe an improvement by a factor of 6 in the atom loading rate of a narrow-line Yb MOT. The relative simplicity and generality of this approach make it readily adoptable to other experiments involving narrow-line MOTs. We also present a numerical simulation of this two-stage slowing process, which shows good agreement with the observed dependence on experimental parameters, and use it to assess potential improvements to the method.
Collapse
Affiliation(s)
| | - Anna Wirth
- Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - Daniel Gochnauer
- Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | - Tahiyat Rahman
- Department of Physics, University of Washington, Seattle, Washington 98195, USA
| | | | - Subhadeep Gupta
- Department of Physics, University of Washington, Seattle, Washington 98195, USA
| |
Collapse
|
8
|
|
9
|
Wirth A. Schwangere müssen aufs Gewicht achten. MMW Fortschr Med 2020; 162:33. [PMID: 32124356 DOI: 10.1007/s15006-020-0207-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Binkley M, Rauf M, Milgrom S, Pinnix C, Tsang R, Ng A, Roberts K, Gao S, Ricardi U, Levis M, Casulo C, Stolten M, Kelsey C, Brady J, Mikhaeel N, Hoppe B, Terezakis S, Kirova Y, Akhtar S, Maghfoor I, Koenig J, Jackson C, Song E, Segal S, Advani R, Natkunam Y, Constine L, Eich H, Wirth A, Hoppe R. STAGE I-II NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA IN THE MODERN ERA: A MULTI-INSTITUTIONAL EXPERIENCE OF ADULT PATIENTS BY ILROG. Hematol Oncol 2019. [DOI: 10.1002/hon.103_2629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M.S. Binkley
- Radiation Oncology; Stanford University School of Medicine; Stanford United States
| | - M. Rauf
- Medical Oncology; King Faisal Specialist Hospital and Research Centre; Riyadh Saudi Arabia
| | - S.A. Milgrom
- Radiation Oncology; University of Texas MD Anderson Cancer Center; Houston United States
| | - C.C. Pinnix
- Radiation Oncology; University of Texas MD Anderson Cancer Center; Houston United States
| | - R. Tsang
- Radiation Oncology; Princess Margaret Cancer Center; Toronto Canada
| | - A. Ng
- Radiation Oncology; Dana Farber and Harvard University School of Medicine; Boston United States
| | - K.B. Roberts
- Radiation Oncology; Yale University; New Haven United States
| | - S. Gao
- Radiation Oncology; Yale University; New Haven United States
| | - U. Ricardi
- Oncology; University of Turin; Torino Italy
| | - M. Levis
- Oncology; University of Turin; Torino Italy
| | - C. Casulo
- Medical Oncology; University of Rochester; Rochester United States
| | - M. Stolten
- Radiation Oncology; University of Rochester; Rochester United States
| | - C.R. Kelsey
- Radiation Oncology; Duke University School of Medicine; Durham United States
| | - J.L. Brady
- Radiation Oncology; Guy's Cancer Centre, Guy's and St Thomas’ NHS Hospital; London United Kingdom
| | - N. Mikhaeel
- Radiation Oncology; Guy's Cancer Centre, Guy's and St Thomas’ NHS Hospital; London United Kingdom
| | - B.S. Hoppe
- Radiation Oncology; University of Florida; Jacksonville United States
| | - S.A. Terezakis
- Radiation Oncology; The Johns Hopkins University School of Medicine; Baltimore United States
| | - Y. Kirova
- Radiation Oncology; Institut Curie; Paris France
| | - S. Akhtar
- Medical Oncology; King Faisal Specialist Hospital and Research Centre; Riyadh Saudi Arabia
| | - I. Maghfoor
- Medical Oncology; King Faisal Specialist Hospital and Research Centre; Riyadh Saudi Arabia
| | - J.L. Koenig
- Radiation Oncology; Stanford University School of Medicine; Stanford United States
| | - C. Jackson
- Radiation Oncology; Yale University; New Haven United States
| | - E. Song
- Radiation Oncology; Duke University School of Medicine; Durham United States
| | - S. Segal
- Radiation Oncology; The Johns Hopkins University School of Medicine; Baltimore United States
| | - R.H. Advani
- Medical Oncology; Stanford University School of Medicine; Stanford United States
| | - Y. Natkunam
- Pathology; Stanford University School of Medicine; Stanford United States
| | - L.S. Constine
- Radiation Oncology; University of Rochester; Rochester United States
| | - H. Eich
- Radiation Oncology; Munster University; Munster Germany
| | - A. Wirth
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - R.T. Hoppe
- Radiation Oncology; Stanford University School of Medicine; Stanford United States
| |
Collapse
|
11
|
MacManus M, Campbell B, Wirth A, Hofman M, Hicks R, Seymour J, Burbury K. ABSCOPAL REGRESSION OF LYMPHOMA AT DISTANT SITES AFTER LOCAL RADIOTHERAPY, DETECTED BY POSITRON EMISSION TOMOGRAPHY IN SIX CASES. Hematol Oncol 2019. [DOI: 10.1002/hon.236_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- M.P. MacManus
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - B. Campbell
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - A. Wirth
- Radiation Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - M. Hofman
- Molecular Imaging; Peter MacCallum Cancer Centre; Melbourne Australia
| | - R. Hicks
- Molecular Imaging; Peter MacCallum Cancer Centre; Melbourne Australia
| | - J. Seymour
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - K. Burbury
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| |
Collapse
|
12
|
MacManus M, Roos D, O'Brien P, Tsang R, Wirth A, Capp A, Bressel M, Seymour J. RESULTS OF A MULTICENTER PHASE2 TRIAL OF INVOLVED FIELD RADIOTHERAPY ALONE FOR LOCALIZED NON-GASTRIC MARGINAL ZONE LYMPHOMA: TROG 05.02. Hematol Oncol 2019. [DOI: 10.1002/hon.36_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- M.P. MacManus
- Radiation Oncology; Peter MacCallum cancer Centre; Melbourne Australia
| | - D. Roos
- Radiation Oncology; Royal Adelaide Hospital; Adelaide Australia
| | - P. O'Brien
- Radiation Oncology; Genesis Care Lake Macquarie Private Hospital; Gateshead Australia
| | - R. Tsang
- Radiation Oncology; Princess Margaret Hospital; Totonto Canada
| | - A. Wirth
- Radiation Oncology; Peter MacCallum cancer Centre; Melbourne Australia
| | - A. Capp
- Radiation Oncology; Calvary Mater Hospital; Waratah Australia
| | - M. Bressel
- Radiation Oncology; Peter MacCallum cancer Centre; Melbourne Australia
| | - J. Seymour
- Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| |
Collapse
|
13
|
Newman S, Bucknell N, Bressel M, Tran P, Campbell B, Haghighi N, Kok D, MacManus M, Phillips C, Shaw M, Wirth A, Wheeler G, Ball D, Siva S. EP-1351 Long-term survival with FDG-PET directed therapy in NSCLC with synchronous solitary brain metastasis. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31771-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
14
|
|
15
|
|
16
|
|
17
|
Ball D, Mai G, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B. Quality of life in the CHISEL randomized trial of stereotactic ablative radiotherapy (SABR) versus standard radiotherapy for stage I non-small cell lung cancer (Trans-Tasman Radiation Oncology Group 09.02). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy445] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
|
19
|
Dabaja BS, Zelenetz AD, Ng AK, Tsang RW, Qi S, Allen PK, Hodgson D, Ricardi U, Hoppe RT, Advani R, Mauch PM, Constine LS, Specht L, Li Y, Terezakis SA, Wirth A, Reinartz G, Eich HT, Aleman BMP, Barr P, Yahalom J. Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG). Ann Oncol 2018; 28:2185-2190. [PMID: 28911068 DOI: 10.1093/annonc/mdx334] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Background Mantle cell lymphoma (MCL) rarely presents as early-stage disease, but clinical observations suggest that patients who present with early-stage disease may have better outcomes than those with advanced-stage disease. Patients and methods In this 13-institution study, we examined outcomes among 179 patients with early-stage (stage I or II) MCL in an attempt to identify prognostic factors that influence treatment selection and outcome. Variables examined included clinical characteristics, treatment modality, response to therapy, sites of failure, and survival. Results Patients were predominantly male (78%) with head and neck being the most common presenting sites (75%). Most failures occurred outside the original disease site (79%). Although the administration of radiation therapy, either alone or with chemotherapy, reduced the risk of local failure, it did not translate into an improved freedom from progression or overall survival (OS). The treatment outcomes were independent of treatment modality. The 10-year OS for patients treated with chemotherapy alone, chemo-radiation therapy and radiation therapy alone were 69%, 62%, and 74% (P = 0.79), and the 10-year freedom from progression were 46%, 43%, and 31% (P = 0.64), respectively. Conclusion Given the excellent OS rates regardless of initial therapy in patients with early-stage MCL, de-intensified therapy to limit treatment-related toxicity is a reasonable approach.
Collapse
Affiliation(s)
- B S Dabaja
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston
| | - A D Zelenetz
- Memorial Sloan-Kettering Cancer Center, New York
| | - A K Ng
- Department of Radiation Oncology, Brigham & Women's Hospital, Boston, USA
| | - R W Tsang
- Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada
| | - S Qi
- Memorial Sloan-Kettering Cancer Center, New York
| | - P K Allen
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston
| | - D Hodgson
- Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada
| | - U Ricardi
- Department of Oncology, University of Turin, Turin, Italy
| | | | | | - P M Mauch
- Department of Radiation Oncology, Brigham & Women's Hospital, Boston, USA
| | - L S Constine
- University of Rochester Medical Center, Rochester, USA
| | - L Specht
- Department of Oncology and Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - Y Li
- Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S A Terezakis
- Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, USA
| | - A Wirth
- Department of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - G Reinartz
- Department of Radiation Oncology, University of Muenster, Muenster, Germany
| | - H T Eich
- Department of Radiation Oncology, University of Muenster, Muenster, Germany
| | - B M P Aleman
- Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - P Barr
- University of Rochester Medical Center, Rochester, USA
| | - J Yahalom
- Memorial Sloan-Kettering Cancer Center, New York
| |
Collapse
|
20
|
Moutin E, Nikonenko I, Stefanelli T, Wirth A, Ponimaskin E, De Roo M, Muller D. Palmitoylation of cdc42 Promotes Spine Stabilization and Rescues Spine Density Deficit in a Mouse Model of 22q11.2 Deletion Syndrome. Cereb Cortex 2018; 27:3618-3629. [PMID: 27365300 DOI: 10.1093/cercor/bhw183] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
22q11.2 deletion syndrome (22q11DS) is associated with learning and cognitive dysfunctions and a high risk of developing schizophrenia. It has become increasingly clear that dendritic spine plasticity is tightly linked to cognition. Thus, understanding how genes involved in cognitive disorders affect synaptic networks is a major challenge of modern biology. Several studies have pointed to a spine density deficit in 22q11DS transgenic mice models. Using the LgDel mouse model, we first quantified spine deficit at different stages using electron microscopy. Next we performed repetitive confocal imaging over several days on hippocampal organotypic cultures of LgDel mice. We show no imbalanced ratio between daily spine formation and spine elimination, but a decreased spine life expectancy. We corrected this impaired spine stabilization process by overexpressing ZDHHC8 palmitoyltransferase, whose gene belongs to the LgDel microdeletion. Overexpression of one of its substrates, the cdc42 brain-specific variant, under a constitutively active form (cdc42-palm-CA) led to the same result. Finally, we could rescue spine density in vivo, in adult LgDel mice, by injecting pups with a vector expressing cdc42-palm-CA. This study reveals a new role of ZDHHC8-cdc42-palm molecular pathway in postsynaptic structural plasticity and provides new evidence in favor of the dysconnectivity hypothesis for schizophrenia.
Collapse
Affiliation(s)
- E Moutin
- Department of Basic Neurosciences, Medical School, University of Geneva, 1211 Geneva 4, Switzerland
| | - I Nikonenko
- Department of Basic Neurosciences, Medical School, University of Geneva, 1211 Geneva 4, Switzerland
| | - T Stefanelli
- Department of Basic Neurosciences, Medical School, University of Geneva, 1211 Geneva 4, Switzerland
| | - A Wirth
- Cellular Neurophysiology, Hannover Medical School, 30625 Hannover, Germany
| | - E Ponimaskin
- Cellular Neurophysiology, Hannover Medical School, 30625 Hannover, Germany
| | - M De Roo
- Department of Basic Neurosciences, Medical School, University of Geneva, 1211 Geneva 4, Switzerland
| | - D Muller
- Department of Basic Neurosciences, Medical School, University of Geneva, 1211 Geneva 4, Switzerland
| |
Collapse
|
21
|
Wirth A. Der kerngesunde Adipöse — ein Mythos? MMW Fortschr Med 2018; 160:35. [PMID: 29557002 DOI: 10.1007/s15006-018-0285-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
22
|
Wirth A. Abspecken vor Herz-OP wohl unnötig. MMW Fortschr Med 2018; 160:35. [PMID: 29464626 DOI: 10.1007/s15006-018-0193-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Wirth A. Sollten dicke KHK-Patienten abnehmen? MMW Fortschr Med 2017; 159:46. [PMID: 29124586 DOI: 10.1007/s15006-017-0274-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
24
|
Ball D, Mai T, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Vanevski M, Shaw M. MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL). J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.565] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Pinnix C, Wirth A, Milgrom S, Andraos T, Aristophanous M, Pham M, Hancock D, Ludmir E, Fanale M, Oki Y, Nastoupil L, Mikhaeel G, Dabaja B. Omission of Cardiophrenic Lymph Nodes in the Treatment of Patients with Hodgkin Lymphoma Using Modified Involved Site Radiation Therapy: Lower Toxicity with No Added Failure. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
26
|
|
27
|
|
28
|
Hauner H, Moss A, Berg A, Bischoff S, Colombo-Benkmann M, Ellrott T, Kanthak U, Kunze D, Stefan N, Teufel M, Wabitsch M, Wirth A. Prävention und Therapie der Adipositas. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0042-114746] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- H. Hauner
- Klinik für Ernährungsmedizin, Klinikum rechts der Isar, Technische Universität München
| | - A. Moss
- Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm
| | - A. Berg
- Institut für Sport und Sportwissenschaft der Universität Freiburg, Freiburg
| | - S. Bischoff
- Institut für Ernährungsmedizin, Universität Hohenheim, Stuttgart
| | | | - T. Ellrott
- Institut für Ernährungspsychologie, Georg-August-Universität, Göttingen
| | - U. Kanthak
- Adipositaschirurgie Selbsthilfe Deutschland e. V
| | - D. Kunze
- Kinderendokrinologische Praxis, München
| | - N. Stefan
- Institute of Diabetes Research and Metabolic Diseases IDM, Universitätsklinikum Tübingen
| | - M. Teufel
- Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Tübingen
| | - M. Wabitsch
- Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm
| | | |
Collapse
|
29
|
Schlier B, Lange P, Wiese S, Wirth A, Lincoln T. The effect of educational information about treatments for schizophrenia on stigmatizing perceptions. J Behav Ther Exp Psychiatry 2016; 52:11-16. [PMID: 26949924 DOI: 10.1016/j.jbtep.2016.02.002] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/19/2015] [Revised: 02/22/2016] [Accepted: 02/22/2016] [Indexed: 11/29/2022]
Abstract
BACKGROUND A promising strategy for reducing stigmatizing perceptions towards people with schizophrenia is education about treatment and recovery. The effects of different kinds of treatment information on stigmatizing perceptions, however, have yet to be compared directly. This study compared three different educational interventions focusing on medication, CBT, and psychodynamic psychotherapy in their potential to reduce stigmatizing perceptions towards people with schizophrenia. METHODS In an online experiment 178 participants received one of three psychoeducation texts that focused on medication, CBT or psychodynamic therapy. The effects on stereotypical beliefs about psychosis (dangerousness, unpredictability, blame, prognostic pessimism) and emotional responses towards people with schizophrenia (anxiety, anger, sympathy) were tested. RESULTS Perceptions of dangerousness, unpredictability, and anxiety towards people with schizophrenia were reduced in all conditions. Prognostic pessimism was reduced only after reading the CBT information. LIMITATIONS No neutral control group was included. The sample was not representative with respect to level of education or gender. CONCLUSIONS Stigmatizing perceptions may be reduced by receiving information about any type of treatment for psychosis and without producing negative side-effects, although this needs to be replicated in a controlled study. However, information on CBT seems most suitable to reduce stigma, since it was able to reduce prognostic pessimism.
Collapse
Affiliation(s)
- Björn Schlier
- University of Hamburg, Department of Clinical Psychology and Psychotherapy, Von-Melle-Park 5, D-20146 Hamburg, Germany.
| | - Pia Lange
- University of Hamburg, Department of Clinical Psychology and Psychotherapy, Von-Melle-Park 5, D-20146 Hamburg, Germany
| | - Salome Wiese
- University of Hamburg, Department of Clinical Psychology and Psychotherapy, Von-Melle-Park 5, D-20146 Hamburg, Germany
| | - Anna Wirth
- University of Hamburg, Department of Clinical Psychology and Psychotherapy, Von-Melle-Park 5, D-20146 Hamburg, Germany
| | - Tania Lincoln
- University of Hamburg, Department of Clinical Psychology and Psychotherapy, Von-Melle-Park 5, D-20146 Hamburg, Germany
| |
Collapse
|
30
|
|
31
|
|
32
|
Hauner H, Moss A, Berg A, Bischoff S, Colombo-Benkmann M, Ellrott T, Kanthak U, Kunze D, Stefan N, Teufel M, Wabitsch M, Wirth A. Prävention und Therapie der Adipositas. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1553575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- H. Hauner
- Institut für Ernährungsmedizin, Klinikum rechts der Isar, Technische Universität München
| | - A. Moss
- Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm
| | - A. Berg
- Institut für Sport und Sportwissenschaft der Universität Freiburg, Freiburg
| | - S. Bischoff
- Institut für Ernährungsmedizin, Universität Hohenheim, Stuttgart
| | | | - T. Ellrott
- Institut für Ernährungspsychologie, Georg-August-Universität, Göttingen
| | - U. Kanthak
- Adipositaschirurgie Selbsthilfe Deutschland e. V
| | - D. Kunze
- Kinderendokrinologische Praxis, München
| | - N. Stefan
- Institute of Diabetes Research and Metabolic Diseases IDM, Universitätsklinikum Tübingen
| | - M. Teufel
- Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Tübingen
| | - M. Wabitsch
- Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm
| | | |
Collapse
|
33
|
MacManus M, Wirth A, Campbell B, Khor R, Ryan G, Seymour J. High Rate of Progression Free Survival and Exceptional Overall Survival in FDG-PET-Staged Patients With Stage III Follicular Lymphoma Treated With Comprehensive Lymphatic Irradiation. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Ng S, Khor R, Bressel M, MacManus M, Seymour J, Hicks R, Wirth A. Impact of 18-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Stage on Outcomes Among Patients With Early-Stage Follicular Lymphoma. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
35
|
Wirth A. [In atrial fibrillation weight loss is effective]. MMW Fortschr Med 2015; 157:38. [PMID: 26985501 DOI: 10.1007/s15006-015-3657-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
36
|
Wirth A. [Even healthy obese are prone to diabetes]. MMW Fortschr Med 2015; 157:41. [PMID: 26349722 DOI: 10.1007/s15006-015-3471-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
37
|
Wirth A, Cavallacci G, Genovesi-Ebert F. The advantages of an inverted retina. A physiological approach to a teleological question. Dev Ophthalmol 2015; 9:20-8. [PMID: 6098490 DOI: 10.1159/000409800] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
38
|
Wirth A. [Every second obese teenager at risk for coronary heart disease]. MMW Fortschr Med 2015; 157 Suppl 1:30. [PMID: 26012981 DOI: 10.1007/s15006-015-2863-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
39
|
Hauner H, Moss A, Berg A, Bischoff S, Colombo-Benkmann M, Ellrott T, Kanthak U, Kunze D, Stefan N, Teufel M, Wabitsch M, Wirth A. Prävention und Therapie der Adipositas. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0034-1385404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- H. Hauner
- Institut für Ernährungsmedizin, Klinikum rechts der Isar, Technische Universität München
| | - A. Moss
- Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm
| | - A. Berg
- Institut für Sport und Sportwissenschaft der Universität Freiburg, Freiburg
| | - S. Bischoff
- Institut für Ernährungsmedizin, Universität Hohenheim, Stuttgart
| | | | - T. Ellrott
- Institut für Ernährungspsychologie, Georg-August-Universität, Göttingen
| | - U. Kanthak
- Adipositaschirurgie Selbsthilfe Deutschland e. V
| | - D. Kunze
- Kinderendokrinologische Praxis, München
| | - N. Stefan
- Institute of Diabetes Research and Metabolic Diseases IDM, Universitätsklinikum Tübingen
| | - M. Teufel
- Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Tübingen
| | - M. Wabitsch
- Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm
| | | |
Collapse
|
40
|
Wirth A. [Fat people have common cancers]. MMW Fortschr Med 2014; 156 Spec no 2:31. [PMID: 25552010 DOI: 10.1007/s15006-014-3684-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Affiliation(s)
- A Wirth
- Deutschen Adipositas Gesellschaft
| |
Collapse
|
41
|
Dabaja B, Tsang R, Qi S, Allen P, Hodgson D, Ricardi U, Hoppe R, Ng A, Mauch P, Specht L, Li Y, Terezakis S, Wirth A, Reinartz G, Eich H, Aleman B, Constine L, Yahalom J. Favorable Outcome in Stage I-II Mantle Cell Lymphoma: A Report of 160 Patients From the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.629] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Wirth A. [Cardiovascular risk is elevated in overweight pregnant patients]. MMW Fortschr Med 2014; 156:34. [PMID: 24908884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
43
|
Hornby CJ, Kron T, Muir E, Wirth A. Getting tissue out of harm's way. Ann Oncol 2014; 25:915. [PMID: 24667727 DOI: 10.1093/annonc/mdu032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/08/2023] Open
Affiliation(s)
| | - T Kron
- Department of Physical Sciences
| | - E Muir
- Department of Radiotherapy
| | - A Wirth
- Department of Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
| |
Collapse
|
44
|
Wirth A. [Chocolate might reduce weight]. MMW Fortschr Med 2014; 156:32. [PMID: 24908767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
45
|
Eberhard L, Braun S, Wirth A, Schindler HJ, Hellmann D, Giannakopoulos N. The effect of experimental balancing interferences on masticatory performance. J Oral Rehabil 2014; 41:346-52. [DOI: 10.1111/joor.12150] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- L. Eberhard
- Department of Prosthodontics; University of Heidelberg; Heidelberg Germany
| | - S. Braun
- Department of Prosthodontics; University of Heidelberg; Heidelberg Germany
| | - A. Wirth
- Department of Prosthodontics; University of Heidelberg; Heidelberg Germany
| | - H.-J. Schindler
- Department of Prosthodontics; University of Heidelberg; Heidelberg Germany
| | - D. Hellmann
- Department of Prosthodontics; University of Heidelberg; Heidelberg Germany
| | | |
Collapse
|
46
|
Wirth A. [Regular breakfast lowers cardiovascular risk]. MMW Fortschr Med 2014; 156:34. [PMID: 24930305 DOI: 10.1007/s15006-014-0040-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
47
|
Wirth A. Gewichtsreduktion bei Hypertonie: pro. Dtsch Med Wochenschr 2013; 138:2474. [DOI: 10.1055/s-0033-1349635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
48
|
Wirth A. [Is there a "healthy" obese?]. MMW Fortschr Med 2013; 155 Spec No 2:37. [PMID: 24734453 DOI: 10.1007/s15006-013-2388-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
49
|
Hauner H, Buchholz G, Hamann A, Husemann B, Koletzko B, Liebermeister H, Wabitsch M, Westenhöfer J, Wirth A, Wolfram G. Adipositas und Diabetes mellitus. DIABETOL STOFFWECHS 2013. [DOI: 10.1055/s-0033-1355677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- H. Hauner
- Else-Kröner-Fresenius-Zentrum für Ernährungsmedizin der TU München, München Freising-Weihenstephan
| | - G. Buchholz
- c/o Bundesgeschäftsstelle Deutscher Diabetiker Bund e. V., Kassel
| | - A. Hamann
- Diabetes-Klinik Bad Nauheim GmbH, Bad Nauheim
| | - B. Husemann
- Chirurgische Klinik, Dominikus-Krankenhaus, Düsseldorf
| | - B. Koletzko
- Kinderklinik und Kinderpoliklinik im Dr. v. Haunerschen Kinderspital, München
| | | | - M. Wabitsch
- Universitätsklinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm
| | - J. Westenhöfer
- Hochschule für angewandte Wissenschaften, Fachbereich Ökotrophologie, Hamburg
| | - A. Wirth
- Teutoburger-Wald-Klinik, Bad Rothenfelde
| | - G. Wolfram
- Dept. Lebensmittel und Ernährung, Technische Universität München, Freising-Weihenstephan
| |
Collapse
|
50
|
Wirth A. [High protein intake or many carbohydrates for weight loss?]. MMW Fortschr Med 2013; 155:41. [PMID: 24288921 DOI: 10.1007/s15006-013-2279-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
|